A swift response to a "modest" proposal.
作者信息
Cova J L
出版信息
J Natl Cancer Inst. 1992 May 20;84(10):744-5. doi: 10.1093/jnci/84.10.744.
PMID:1573657
Abstract
摘要
相似文献
1
A swift response to a "modest" proposal.对一项“适度”提议的迅速回应。
J Natl Cancer Inst. 1992 May 20;84(10):744-5. doi: 10.1093/jnci/84.10.744.
2
Proposal for assuring technology competency and leadership in medicine.确保医学技术能力和领导力的提议。
J Natl Cancer Inst. 1992 May 20;84(10):742-4. doi: 10.1093/jnci/84.10.742.
3
Assigning care costs associated with therapeutic oncology research: a modest proposal.
J Natl Cancer Inst. 1992 May 20;84(10):760-3. doi: 10.1093/jnci/84.10.760.
4
Who should be responsible?谁应该负责？
Physician Exec. 1996 Jun;22(6):38-9.
5
Will insurers pay for high-tech care?
Med Econ. 1991 Apr 22;68(8):82-6.
6
Experimental therapy--who shall pay?实验性治疗——该由谁来付费？
N Engl J Med. 1991 May 2;324(18):1291-2. doi: 10.1056/NEJM199105023241819.
7
How can Medicare keep pace with cutting-edge technology?
Health Aff (Millwood). 1994 Summer;13(3):137-40. doi: 10.1377/hlthaff.13.3.137.
8
Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.戳破成本泡沫。血管成形术研究本应是个先兆，但预算和混乱阻碍了改革。
Mod Healthc. 2007 Apr 9;37(15):21.
9
HCFA sets new tech coverage criteria.医疗保健财务管理局制定了新的技术覆盖标准。
Mod Healthc. 2000 Jul 10;30(28):32.
10
Defining experimental therapy--a third-party payer's dilemma.定义实验性治疗——第三方支付者的困境。
N Engl J Med. 1990 Dec 13;323(24):1702-4. doi: 10.1056/NEJM199012133232411.
Zotero 插件